Telesis Bio, Inc. (TBIO)
USD 0.49
(-7.55%)
USD 0.49
(-7.55%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -47.72 Million USD | 1.54% |
| 2022 | -48.47 Million USD | -24.42% |
| 2021 | -38.95 Million USD | -116.31% |
| 2020 | -18.01 Million USD | -116.94% |
| 2019 | -8.3 Million USD | 91.48% |
| 2018 | -97.39 Million USD | -46.58% |
| 2017 | -66.44 Million USD | -148.87% |
| 2016 | -26.69 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -8.63 Million USD | 51.17% |
| 2024 Q2 | -12.58 Million USD | -45.71% |
| 2023 Q3 | -10.63 Million USD | -28.29% |
| 2023 Q2 | -8.28 Million USD | 25.47% |
| 2023 Q4 | -17.68 Million USD | -66.37% |
| 2023 FY | -47.72 Million USD | 1.54% |
| 2023 Q1 | -11.11 Million USD | -36.73% |
| 2022 FY | -48.47 Million USD | -24.42% |
| 2022 Q1 | -13.19 Million USD | -5.63% |
| 2022 Q4 | -8.13 Million USD | 33.96% |
| 2022 Q3 | -12.31 Million USD | 16.97% |
| 2022 Q2 | -14.83 Million USD | -12.41% |
| 2021 FY | -38.95 Million USD | -116.31% |
| 2021 Q1 | -7.44 Million USD | -33.3% |
| 2021 Q2 | -9.2 Million USD | -23.64% |
| 2021 Q4 | -12.49 Million USD | -27.15% |
| 2021 Q3 | -9.82 Million USD | -6.77% |
| 2020 Q1 | -3.88 Million USD | 87.5% |
| 2020 Q2 | -4.08 Million USD | -5.21% |
| 2020 Q3 | -4.46 Million USD | -9.38% |
| 2020 Q4 | -5.58 Million USD | -25.04% |
| 2020 FY | -18.01 Million USD | -116.94% |
| 2019 Q4 | -31.03 Million USD | -46.21% |
| 2019 FY | -8.3 Million USD | 91.48% |
| 2019 Q3 | -21.22 Million USD | 23.73% |
| 2019 Q2 | -27.83 Million USD | 16.16% |
| 2019 Q1 | -33.19 Million USD | -449.91% |
| 2018 Q1 | -21.2 Million USD | -31.81% |
| 2018 Q2 | -27.5 Million USD | -29.68% |
| 2018 Q3 | -42.64 Million USD | -55.06% |
| 2018 Q4 | -6.03 Million USD | 85.84% |
| 2018 FY | -97.39 Million USD | -46.58% |
| 2017 FY | -66.44 Million USD | -148.87% |
| 2017 Q1 | -13.95 Million USD | 0.0% |
| 2017 Q2 | -17.93 Million USD | -28.52% |
| 2017 Q3 | -18.46 Million USD | -2.97% |
| 2017 Q4 | -16.09 Million USD | 12.86% |
| 2016 FY | -26.69 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -81.66 Million USD | 41.56% |
| Biotricity, Inc. | -14.09 Million USD | -238.605% |
| Cell MedX Corp. | -142.48 Thousand USD | -33393.817% |
| Dynatronics Corporation | -2.69 Million USD | -1669.05% |
| Nemaura Medical Inc. | -14.14 Million USD | -237.421% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -335.625% |
| RetinalGenix Technologies Inc. | -2.09 Million USD | -2182.474% |
| Sonendo, Inc. | -60.91 Million USD | 21.66% |
| Talis Biomedical Corporation | -62 Million USD | 23.034% |
| Viveve Medical, Inc. | -22.02 Million USD | -116.661% |